v3.26.1
Stock-Based Compensation Stock-Based Compensation (Details)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended
Mar. 31, 2026
USD ($)
$ / shares
shares
RSUs  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | $ $ 93
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition 3 years
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]  
Number of Units, Beginning Balance (shares) | shares 1.7
Number of Units, Granted (shares) | shares 0.7
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Period Increase (Decrease) | shares 0.0 [1]
Number of Units, Vested/exercised (shares) | shares (0.6) [2]
Number of Units, Forfeitures (shares) | shares 0.0 [3]
Number of Units, Ending Balance (shares) | shares 1.8 [4]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Weighted Average Grant Price, Beginning Balance (in dollars per share) | $ / shares $ 49.64
Weighted Average Grant Price, Granted (in dollars per share) | $ / shares 71.50
Share-based Compensation Arrangement by Share-based Payment Award, Performance Increase (Decrease), Wtd Avg Grant Price | $ / shares 0 [1]
Weighted Average Grant Price, Vested/exercised (in dollars per share) | $ / shares 48.17 [2]
Weighted Average Grant Price, Forfeitures (in dollars) | $ / shares 0 [3]
Weighted Average Grant Price, Ending Balance (in dollars per share) | $ / shares $ 58.17
PSUs  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]  
Number of Units, Beginning Balance (shares) | shares 0.9
Number of Units, Granted (shares) | shares 0.3
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Period Increase (Decrease) | shares (0.3) [1]
Number of Units, Vested/exercised (shares) | shares (0.2) [2]
Number of Units, Forfeitures (shares) | shares 0.0 [3]
Number of Units, Ending Balance (shares) | shares 0.7 [5]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Weighted Average Grant Price, Beginning Balance (in dollars per share) | $ / shares $ 46.08
Weighted Average Grant Price, Granted (in dollars per share) | $ / shares 71.50
Share-based Compensation Arrangement by Share-based Payment Award, Performance Increase (Decrease), Wtd Avg Grant Price | $ / shares 43.33 [1]
Weighted Average Grant Price, Vested/exercised (in dollars per share) | $ / shares 42.18 [2]
Weighted Average Grant Price, Forfeitures (in dollars) | $ / shares 0 [3]
Weighted Average Grant Price, Ending Balance (in dollars per share) | $ / shares $ 58.64
PSUs | Probable  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | $ $ 42
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition 2 years 4 months 24 days
NQs  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | $ $ 0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Beginning Balance | shares 0.9
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares 0.0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercised, Weighted Average Grant Date Fair Value | shares (0.1) [2]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | shares 0.0 [3]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Ending Balance | shares 0.8 [6]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price, Beginning Balance | $ / shares $ 43.97
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ / shares 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercised, Weighted Average Grant Date Fair Value | $ / shares 44.38 [2]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Intrinsic Value | $ / shares 0 [3]
Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price, Ending Balance | $ / shares $ 43.93
NQs | Exercisable options  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable | shares 0.8
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period 4 years
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercised, Weighted Average Grant Date Fair Value | $ / shares $ 9.10
[1] Represents a reduction to shares awarded as the Company did not achieve the target performance metrics at the end of the associated performance period.
[2] Upon exercise of NQs and vesting of RSUs and PSUs, the Company issues new shares to participants.
[3] The Company recognizes cancellations and forfeitures as they occur.
[4] Aggregate unrecognized compensation expense related to RSUs was $93 million as of March 31, 2026, which is expected to be recognized over a weighted average period of 3.0 years.
[5] The aggregate unrecognized compensation expense related to PSUs was $42 million as of March 31, 2026, which is expected to be recognized over a weighted average period of 2.4 years.
[6] There were 0.8 million NQs which were exercisable as of March 31, 2026. These exercisable NQs will expire over a weighted average period of 4.0 years and carry a weighted average grant date fair value of $9.10. There was no unrecognized compensation expense for NQs as of March 31, 2026